Erste Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Buy	180,800 +152,000	+528%	+$1.21M	0.01%	399
2025 Q4	$172K	Hold	28,800	–	–	﹤0.01%	554
2025 Q3	$162K	Hold	28,800	–	–	﹤0.01%	564
2025 Q2	$149K	Hold	28,800	–	–	﹤0.01%	792
2025 Q1	$193K	Hold	28,800	–	–	﹤0.01%	473
2024 Q4	$215K	Hold	28,800	–	–	﹤0.01%	483
2024 Q3	$217K	Hold	28,800	–	–	﹤0.01%	477
2024 Q2	$255K	Hold	28,800	–	–	﹤0.01%	463
2024 Q1	$291K	Hold	28,800	–	–	﹤0.01%	463
2023 Q4	$296K	Hold	28,800	–	–	﹤0.01%	462
2023 Q3	$265K	Hold	28,800	–	–	﹤0.01%	462
2023 Q2	$719K	Hold	28,800	–	–	0.01%	386
2023 Q1	$662K	Hold	28,800	–	–	0.01%	401
2022 Q4	$723K	Hold	28,800	–	–	0.02%	394
2022 Q3	$550K	Hold	28,800	–	–	0.01%	411
2022 Q2	$749K	Hold	28,800	–	–	0.02%	390
2022 Q1	$746K	Sell	28,800 -4,500	-14%	-$133K	0.01%	386
2021 Q4	$1.3M	Hold	33,300	–	–	0.02%	333
2021 Q3	$1.44M	Hold	33,300	–	–	0.03%	306
2021 Q2	$1.55M	Hold	33,300	–	–	0.03%	311
2021 Q1	$1.59M	Hold	33,300	–	–	0.04%	296
2020 Q4	$952K	Buy	+33,300	New	+$1.08M	0.03%	341